Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ChemoCentryx nets $48.1mm in initial public offering

Executive Summary

Just over three years after withdrawing an S-1 due to market conditions, ChemoCentryx Inc. (therapeutics targeting the chemokine system) has finally gone public. The company netted $48.1mm by selling 5.2mm shares (including the overallotment) at $10. Last month it had planned to offer slightly fewer shares (4mm), but at a higher range, $14-16.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies